₹-0.01
(Market cap
₹31 Cr
Revenue (TTM)
₹147 Cr
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-2 Cr
-
ROE
4.9 %
-
ROCE
1 %
-
Industry P/E
34.55
-
EV/EBITDA
1156.5
-
Debt to Equity
26.4
-
Book Value
₹1
-
EPS
₹-0
-
Face value
1
-
Shares outstanding
881,990,132
10 Years Aggregate
CFO
₹-1,189.12 Cr
EBITDA
₹45.08 Cr
Net Profit
₹42.16 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Remedium Lifecare
| -53.3 | -23.9 | -36.4 | -78.8 | -70.0 | -10.1 | -- |
|
BSE Healthcare
| 7.1 | 4.2 | 6.3 | 9.1 | 24.6 | 13.5 | 11.9 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Remedium Lifecare
| -78.8 | -79.5 | 1,895.6 | 1.2 | 192.9 | 111.0 | 35.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Remedium Lifecare
|
0.4 | 30.9 | 146.7 | -2.2 | -9.5 | -3.2 | -- | 0.3 |
| 2,929.2 | 36,613.0 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 34.7 | 8.1 | |
| 8,557.0 | 21,370.8 | 2,275.6 | 187.5 | 10.3 | 22.9 | 114 | 24.5 | |
| 1,972.9 | 15,008.9 | 2,187.2 | 649.7 | 31.5 | 19 | 23.4 | 4.2 | |
| 1,703.0 | 10,378.0 | 1,196.4 | 149.4 | -- | 27.5 | 56.1 | 13.9 | |
| 1,397.1 | 19,342.6 | 3,129.4 | 647.4 | 26.9 | 18.1 | 31.2 | 5.0 | |
| 2,140.0 | 34,351.5 | 4,147.8 | 709.5 | 22.3 | 19.1 | 48.4 | 8.3 | |
| 4,465.5 | 20,444.0 | 2,519.7 | 722.4 | 33.6 | 18.8 | 28.3 | 4.9 | |
| 6,108.5 | 10,147.3 | 1,408.0 | 326.9 | 30.8 | 57.1 | 31 | 19.3 | |
| 1,081.2 | 9,962.0 | 4,858.7 | 574.1 | 14.9 | 19.7 | 17.9 | 3.2 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Stock Rating update, March 15, 2024
2 min read•By Value Research
About Remedium Lifecare
Non-specialized wholesale trade
-
Incorporated
1988
-
Chairman
Rambhajan Vishwakarma
-
Managing Director
--
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Remedium Lifecare Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Remedium Lifecare
What is the current share price of Remedium Lifecare Ltd Today?
The share price of Remedium Lifecare Ltd is ₹0.35 (BSE) as of 03-Jun-2026 IST. Remedium Lifecare Ltd has given a return of -70% in the last 3 years.
What is the current PB & PE ratio of Remedium Lifecare Ltd?
Since, TTM earnings of Remedium Lifecare Ltd is negative, P/E ratio is not available.
The P/B ratio of Remedium Lifecare Ltd is 0.34 times as on 03-Jun-2026, a 93 discount to its peers’ median range of 4.61 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
24.06
|
1.67
|
|
2024
|
5.83
|
25.46
|
|
2023
|
1.75
|
25.62
|
|
2022
|
46.26
|
10.10
|
|
2021
|
32.97
|
4.11
|
What is the 52 Week High and Low of Remedium Lifecare Ltd?
The 52-week high and low of Remedium Lifecare Ltd are Rs 1.80 and Rs 0.32 as of 04-Jun-2026.
What is the market cap of Remedium Lifecare Ltd?
Remedium Lifecare Ltd has a market capitalisation of ₹ 31 Cr as on 03-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Remedium Lifecare Ltd?
Before investing in Remedium Lifecare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.